Phibro’s (PAHC) Big Acquisition Bet Just Cleared Its First Full Year
Phibro Animal Health completed its first full fiscal year following a significant acquisition of a medicated feed additive portfolio, with results released on August 27. The company reported full-year net sales of $1.5 billion, adjusted EBITDA that rose 39% to $255 million, and adjusted diluted earnings per share that increased 48% to $3.22 for the year ended June 30.
The acquired feed additive business contributed $354.3 million in sales and grew 70% during the full year. Beyond the acquisitio
Read more »